Atlas Trials

Aflibercept Injection for Proliferative Diabetic Retinopathy

Clinical trial NCT01805297 · COMPLETED

Trial details

NCT number
NCT01805297
Sponsor
University of Oklahoma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Vitreous Hemorrhage
Start date
2013-03-01
Primary completion
2014-02-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.